Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population: A SEER based analysis from 2000-2016. Comparison of treatment costs for pembrolizumab versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results